Earnings from Surmodics Inc. [SRDX] are scheduled on April 28, 2021, before the market opens. It is expected that the company will report strong earnings for the quarter ending Mar 2021.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .
SRDX Stock Earnings Outlook For The Current Quarter
The consensus estimates for the quarter suggest that the company would earn $0.63 per share on revenue of $32.95M. Taking a look at the future, the company is projected to report revenue of $23.34M at an earnings per share of -$0.12 for the Jun 2021 quarter. The estimates represent year-over-year improvements of 14.50% in revenue and 159.52% in earnings per share for the company.
SRDX Stock Earnings Forecast For The Current Year
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
For the full financial year, Surmodics Inc. [NASDAQ:SRDX] is forecasted to generate revenue of $101.48M. The figure is about $6.62 million above what the company actually reported for the fiscal year 2020. In terms of EPS, it is estimated to be $0.37 in 2021, which is $0.24 higher than the figure in FY20. Based on current estimates, earnings are expected to grow 184.60% this year, 162.20% next year, and 10.00% annually over the next five years. With regard to sales, forecasts suggest an incline of 7.00% in current fiscal year and 14.50% over following year.
SRDX Stock Price Performance
At the close of Tuesday’s session, Surmodics Inc. [NASDAQ:SRDX] finished up 0.12% at $58.95. The stock’s highest single-day price was $59.42, and its lowest was $58.1825. Its price rose 2.50% in the last five days. Since the beginning of the year, Surmodics Inc.’s shares are up nearly 35.45%. However, the share price is -1.34% below its one year high. The top price reached by the shares of the company was $59.75 on 04/16/21, while the 52-week low came on 01/11/21, when the shares were $41.59. In the past year, shares of the company have risen 58.68%. At 50 days, the moving average achieved is $54.87 while at 200 days, the moving average is $45.59. There were 30721.0 shares traded in the last session, up from 25300.0 in the previous session.
Surmodics Inc. [NASDAQ:SRDX] Stock Valuation Metrics
With a prevailing 12-month PE ratio of 1281.52, Surmodics Inc. [SRDX] does not qualify as a good candidate for the list of underestimated low-priced stocks that should be purchased sooner rather than later. By this measure, the company’s stock is trading at a premium to the industry average of 36.41 times trailing earnings. Investors may find it helpful to look at historical price-sales ratios, and in the case of this stock, 8.66 PS value ratio is reported for the last one year of reported earnings. This is above the average return 5.87 for the industry, which means SRDX offers an unattractive investment opportunity than its competitors do.
SRDX Share Price Support And Resistance Levels
Based on the daily chart, the immediate backing lies around the 58.95 level, and the violation of this level will cause a further drop to 58.28 level. At the upper end, 60.76 remains a key resistance. As the stock increases, it may find resistance at 60.09. In the 14-day chart, the Relative Strength Index standing at 62.66 suggests a technical neutral stance while the MACD standing at 0.66 indicates price will decrease in the next trading period. Stochastic %K at 75.99% suggests holding the stock while Percent R indicator at 17.90% suggests bullish price movement.
How much is the short interest in Surmodics Inc.?
There have been a drop in short interest in the Surmodics Inc. Financial stock, with short interest up by 31950.0 shares to 0.35 million shares on Mar 14, 2021. According to data provided by Yahoo Finance, the short interest on Apr 14, 2021 stood at 0.39 million shares. This -9.04% decrease suggests some bullish sentiment was experienced by the stock. Shorted shares accounted for just 4.20% of the overall float in the stock, while the stock’s days to cover moved to 6.43.
How do analysts view Surmodics Inc.?
In regard to the share price forecast for Surmodics Inc. stock, the analysts, as surveyed by FactSet, forecast the price to reach $73.00 in the next twelve months, representing almost an 19.25% growth from its recent price of $58.95. Among Surmodics Inc. stock projections, $76.00 is the highest analyst target for the stock, while $61.00 is the lowest. Despite this, 4 analysts who share their consensus rating for SRDX in 2021 agree that the stock is a Buy. The latest rating change took place on 7/23/20, when Needham Ratings upgraded the stock from “Hold” to “Buy.”